Terms: = Liver cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Treatment
93 results:
1. Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
Cao B; Wang Y; Lu H; Huang C; Yang Y; Shang L; Chen Z; Jiang R; Liu Y; Lin L; Peng P; Wang F; Gong F; Hu H; Cheng C; Yao X; Ye X; Zhou H; Shen Y; Liu C; Wang C; Yi Z; Hu B; Xu J; Gu X; Shen J; Xu Y; Zhang L; Fan J; Tang R; Wang C
N Engl J Med; 2024 Jan; 390(3):230-241. PubMed ID: 38231624
[TBL] [Abstract] [Full Text] [Related]
2. Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202.
Kobayashi S; Nakachi K; Ikeda M; Konishi M; Ogawa G; Sugiura T; Yanagimoto H; Morinaga S; Wada H; Shimada K; Takahashi Y; Nakagohri T; Kamata K; Shimizu Y; Ajiki T; Hirano S; Gotohda N; Ueno M; Okusaka T; Furuse J
Eur J Surg Oncol; 2024 Feb; 50(2):107324. PubMed ID: 38157649
[TBL] [Abstract] [Full Text] [Related]
3. [Analysis and prediction of burden of viral hepatitis C-associated diseases in China from 1990 to 2044].
Zhou M; Yao L; Wu Y; Lin S; Huang J
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Dec; 35(5):476-485. PubMed ID: 38148536
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of the Prognostic Role of liver Metastases on Patient Outcomes: Systematic Review and Meta-analysis.
Waninger JJ; Ma VT; Chopra Z; Pearson AN; Green MD
Cancer J; 2023 Sep-Oct 01; 29(5):279-284. PubMed ID: 37796646
[TBL] [Abstract] [Full Text] [Related]
5. Novel models by machine learning to predict prognosis of breast cancer brain metastases.
Li C; Liu M; Zhang Y; Wang Y; Li J; Sun S; Liu X; Wu H; Feng C; Yao P; Jia Y; Zhang Y; Wei X; Wu F; Du C; Zhao X; Zhang S; Qu J
J Transl Med; 2023 Jun; 21(1):404. PubMed ID: 37344847
[TBL] [Abstract] [Full Text] [Related]
6. TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study.
Yuan Y; He W; Yang Z; Qiu J; Huang Z; Shi Y; Lin Z; Zheng Y; Chen M; Lau WY; Li B; Yuan Y
Int J Surg; 2023 May; 109(5):1222-1230. PubMed ID: 37026861
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of Characteristics and Risk Factors of Patients with Single Gastric cancer and Synchronous Multiple Gastric cancer among 14,603 Patients.
Song DH; Kim N; Jo HH; Kim S; Choi Y; Oh HJ; Lee HS; Yoon H; Shin CM; Park YS; Lee DH; Kang SH; Park YS; Ahn SH; Suh YS; Park DJ; Kim HH; Kim JW; Kim JW; Lee KW; Chang W; Park JH; Lee YJ; Lee KH; Kim YH; Ahn S; Surh YJ
Gut Liver; 2024 Mar; 18(2):231-244. PubMed ID: 36987384
[TBL] [Abstract] [Full Text] [Related]
8. Laparoscopic modular extended right posterior sectionectomy for hepatocellular carcinoma guided by projection plane extension from the right hepatic vein.
Lin J; Fang C; Yang J
J Gastrointest Surg; 2023 Jul; 27(7):1494-1495. PubMed ID: 36932306
[TBL] [Abstract] [Full Text] [Related]
9. Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
Talbot T; D'Alessio A; Pinter M; Balcar L; Scheiner B; Marron TU; Jun T; Dharmapuri S; Ang C; Saeed A; Hildebrand H; Muzaffar M; Fulgenzi CAM; Amara S; Naqash AR; Gampa A; Pillai A; Wang Y; Khan U; Lee PC; Huang YH; Bengsch B; Bettinger D; Mohamed YI; Kaseb A; Pressiani T; Personeni N; Rimassa L; Nishida N; Kudo M; Weinmann A; Galle PR; Muhammed A; Cortellini A; Vogel A; Pinato DJ
Liver Int; 2023 Mar; 43(3):695-707. PubMed ID: 36577703
[TBL] [Abstract] [Full Text] [Related]
10. Natural history of decompensated cirrhosis with serum hepatitis B DNA < 2000 IU/mL: a retrospective study.
Huang X; Yan M; Deng Z; Yao L; Han D; Sun L
BMC Gastroenterol; 2022 Nov; 22(1):452. PubMed ID: 36352372
[TBL] [Abstract] [Full Text] [Related]
11. Incidence and risk of severe adverse events associated with trastuzumab emtansine (T-DM1) in the treatment of breast cancer: an up-to-date systematic review and meta-analysis of randomized controlled clinical trials.
Liu K; Li YH; Zhang X; Su L; Li JH; Shi HY; Zhang JH
Expert Rev Clin Pharmacol; 2022 Nov; 15(11):1343-1350. PubMed ID: 36062413
[TBL] [Abstract] [Full Text] [Related]
12. Arterial enhancement fraction in evaluating the therapeutic effect and survival for hepatocellular carcinoma patients treated with DEB-TACE.
Chai B; Xiang D; Wang W; Ren Y; Wang F; Wang J; Zhou G; Zheng C
Cancer Imaging; 2022 Jul; 22(1):38. PubMed ID: 35908071
[TBL] [Abstract] [Full Text] [Related]
13. Pharmacogenetics of taxane-induced neurotoxicity in breast cancer: Systematic review and meta-analysis.
Guijosa A; Freyria A; Espinosa-Fernandez JR; Estrada-Mena FJ; Armenta-Quiroga AS; Ortega-Treviño MF; Catalán R; Antonio-Aguirre B; Villarreal-Garza C; Perez-Ortiz AC
Clin Transl Sci; 2022 Oct; 15(10):2403-2436. PubMed ID: 35892315
[TBL] [Abstract] [Full Text] [Related]
14. Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort.
Parikh ND; Tayob N; Al-Jarrah T; Kramer J; Melcher J; Smith D; Marquardt P; Liu PH; Tang R; Kanwal F; Singal AG
JAMA Netw Open; 2022 Jul; 5(7):e2223504. PubMed ID: 35867057
[TBL] [Abstract] [Full Text] [Related]
15. Prevalence and role of low skeletal muscle mass (LSMM) in hepatocellular carcinoma. A systematic review and meta-analysis.
March C; Omari J; Thormann M; Pech M; Wienke A; Surov A
Clin Nutr ESPEN; 2022 Jun; 49():103-113. PubMed ID: 35623801
[TBL] [Abstract] [Full Text] [Related]
16. Serum Mac-2 binding protein level predicts the development of liver-related events and colorectal cancer in patients with NAFLD.
Kamada Y; Nakahara T; Munekage K; Fujii H; Sawai Y; Doi Y; Ono M; Hyogo H; Sumida Y; Morishita K; Asuka T; Ouchida T; Imai Y; Miyoshi E;
Hepatol Commun; 2022 Jul; 6(7):1527-1536. PubMed ID: 35478356
[TBL] [Abstract] [Full Text] [Related]
17. COVID-19 and liver cancer: lost patients and larger tumours.
Geh D; Watson R; Sen G; French JJ; Hammond J; Turner P; Hoare T; Anderson K; McNeil M; McPherson S; Masson S; Dyson J; Donnelly M; MacDougal L; Patel P; Hudson M; Anstee QM; White S; Robinson S; Pandanaboyana S; Walker L; McCain M; Bury Y; Raman S; Burt A; Parkinson D; Haugk B; Darne A; Wadd N; Asghar S; Mariappan L; Margetts J; Stenberg B; Scott J; Littler P; Manas DM; Reeves HL
BMJ Open Gastroenterol; 2022 Apr; 9(1):. PubMed ID: 35450934
[TBL] [Abstract] [Full Text] [Related]
18. Tenofovir vs. entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy.
Shen J; Qi W; Dai J; Leng S; Jiang K; Zhang Y; Ran S; Li C; Wen T
Chin Med J (Engl); 2021 Dec; 135(3):301-308. PubMed ID: 34958539
[TBL] [Abstract] [Full Text] [Related]
19. Arterial chemoembolisation with cisplatin versus epirubicin for hepatocellular carcinoma (ACE 500 study): A multicentre, randomised controlled phase 2/3 trial.
Aramaki O; Takayama T; Moriguchi M; Sakamoto H; Yodono H; Kokudo N; Yamanaka N; Kawasaki S; Sasaki Y; Kubota K; Otsuji E; Tanaka S; Matsuyama Y; Fujii M;
Eur J Cancer; 2021 Nov; 157():373-382. PubMed ID: 34563992
[TBL] [Abstract] [Full Text] [Related]
20. Cachexia is Prevalent in Patients With Hepatocellular Carcinoma and Associated With Worse Prognosis.
Rich NE; Phen S; Desai N; Mittal S; Yopp AC; Yang JD; Marrero JA; Iyengar P; Infante RE; Singal AG
Clin Gastroenterol Hepatol; 2022 May; 20(5):e1157-e1169. PubMed ID: 34555519
[TBL] [Abstract] [Full Text] [Related]
[Next]
